Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.305 EUR | -0.97% | +0.49% | -21.79% |
Apr. 04 | Celyad Oncology SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Feb. 09 | Celyad Oncology Seeks Termination of Reporting Obligations to US SEC | MT |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
13.77M | - | - | - | - | - | |
48.16B | - | |||||
41.73B | ||||||
41.03B | ||||||
28.77B | ||||||
25.59B |
- Stock Market
- Equities
- CYAD Stock
- Charts Celyad Oncology SA
- Sector Chart